Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories Ltd has informed BSE that its Board of Directors will meet on Wednesday, November 12, 2025. The main agenda is to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2025, along with the Limited Review Report from auditors. The trading window for designated persons and their immediate relatives will remain closed until 48 hours after the board meeting concludes. The company had previously closed the trading window from September 26, 2025 onward. No specific financial figures are disclosed in this intimation.
This is a routine regulatory filing ahead of the upcoming Q2 FY26 results. Investors should watch for the actual results announcement on or after November 12, 2025, which could trigger short-term price movement depending on the numbers reported.